# Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma

> **NCT07664891** · — · RECRUITING · sponsor: **Institut Paoli-Calmettes** · enrollment: 64 (estimated)

## Conditions studied

- Pancreatic Adenocarcinoma Metastatic

## Interventions

- **OTHER:** Biopsy collection
- **OTHER:** Blood collection

## Key facts

- **NCT ID:** NCT07664891
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-11
- **Primary completion:** 2028-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 64 (ESTIMATED)
- **Last updated:** 2026-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07664891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07664891, "Metabolic Reprogramming and Microenvironment in Pancreatic Adenocarcinoma". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07664891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*